BUSSEROLE
Food supplement declared in France, declaration No 2016-7-758
BUSSEROLE (ACB PHARMA) is a food supplement declared in France. Status: retiré du marché le 9 October 2024. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- ACB PHARMA
- Food business operator placing the product on the market
- ACBNature
- Status
- Retiré du marché le 9 October 2024
- Form
- Gélule
- Daily dose
- 3
- Directions for use
- A utiliser dans le cadre d'une alimentation équilibrée
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Insuffisance rénale
Declaration 156216, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 9 October 2024, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Arctostaphylos uva-ursi (L.) Spreng. | Feuille | Poudre (de plantes séchées ou broyées) | 750 mg |
Other ingredients
gélatine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la dose journalière recommandée. L'utilisation ne doit pas dépasser plus d'une semaine.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : ACB PHARMA